Literature DB >> 12627299

Effects of inducing physiological hyperglucagonemia on metabolic responses to exercise.

Patrice Bélanger1, Yovan Fillion, Karine Couturier, Marie-Soleil Gauthier, Jean-Marc Lavoie.   

Abstract

The purpose of the present study was to assess the effects of exogenously increasing the circulating levels of glucagon on the metabolic responses to exercise in rats. A total of six groups of rats were infused (iv) either with glucagon (20 or 50 ng x kg(-1) x min(-1)) or saline (0.9% NaCl), either in the resting state or during a bout of running exercise (45 min, 26 m x min(-1), 0% grade). Blood samples were taken at the end of the 45-min experiment. Animals infused with glucagon at 50 ng x kg(-1) x min(-1) showed significantly (P<0.01) higher mean plasma glucagon concentrations than animals infused with saline or glucagon at 20 ng x kg(-1) x min(-1). In addition, exercise resulted in significantly (P<0.05) higher mean plasma glucagon concentrations, compared to rest, in all groups. In spite of these differences in glucagon concentrations, there were no significant (P>0.05) effects of exercise and glucagon infusion on mean hepatic glycogen, plasma glucose, insulin, C-peptide, beta-hydroxybutyrate, or catecholamine concentrations. Although exercise resulted in a significant (P<0.01) increase in plasma glycerol and free fatty acid concentrations and a significant (P<0.05) decrease in glycogen in the soleus muscle, these responses were not affected by the glucagon infusion. These results suggest that the liver is non-responsive to physiological hyperglucagonemia in a short-term (45 min) exercise situation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12627299     DOI: 10.1007/s00421-002-0766-2

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  15 in total

1.  Glucagon inhibits urinary acidification in the rat.

Authors:  M Delahousse; O Mercier; M Bichara; M Paillard; F Leviel; R Assan
Journal:  Am J Physiol       Date:  1988-05

2.  Effects of dietary manipulations and glucose infusion on glucagon response during exercise in rats.

Authors:  M Tadjoré; R Bergeron; M Latour; F Désy; C Warren; J M Lavoie
Journal:  J Appl Physiol (1985)       Date:  1997-07

3.  Effect of selective hepatic vagotomy on plasma FFA levels in resting and exercising rats.

Authors:  J M Lavoie; M Lord; A Paulin
Journal:  Am J Physiol       Date:  1988-04

4.  Determination of glycogen in small tissue samples.

Authors:  S Lo; J C Russell; A W Taylor
Journal:  J Appl Physiol       Date:  1970-02       Impact factor: 3.531

Review 5.  Regulation of glucose fluxes during exercise in the postabsorptive state.

Authors:  D H Wasserman
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

Review 6.  Hepatic regulation of pancreatic alpha-cell function.

Authors:  U M Kabadi
Journal:  Metabolism       Date:  1993-05       Impact factor: 8.694

7.  Role of glucagon in regulation of glucose production in exercising dogs.

Authors:  B Issekutz; M Vranic
Journal:  Am J Physiol       Date:  1980-01

8.  Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.

Authors:  D H Wasserman; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  Glucagon acts in the liver to control spontaneous meal size in rats.

Authors:  N Geary; J Le Sauter; U Noh
Journal:  Am J Physiol       Date:  1993-01

10.  Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration.

Authors:  I Magnusson; D L Rothman; D P Gerard; L D Katz; G I Shulman
Journal:  Diabetes       Date:  1995-02       Impact factor: 9.461

View more
  1 in total

1.  Long-term hyperglucagonaemia induces early metabolic and renal phenotypes of Type 2 diabetes in mice.

Authors:  Xiao C Li; Tang-Dong Liao; Jia L Zhuo
Journal:  Clin Sci (Lond)       Date:  2008-05       Impact factor: 6.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.